{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:22:05Z","timestamp":1774714925212,"version":"3.50.1"},"reference-count":20,"publisher":"Zhejiang University Press","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1631\/jzus.b1200120","type":"journal-article","created":{"date-parts":[[2012,9,2]],"date-time":"2012-09-02T23:50:46Z","timestamp":1346629846000},"page":"745-750","source":"Crossref","is-referenced-by-count":18,"title":["Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety"],"prefix":"10.1631","volume":"13","author":[{"given":"Xiao-hong","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-you","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-liang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2012,9,4]]},"reference":[{"issue":"4","key":"3280_CR1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2230.2007.02676.x","volume":"33","author":"R.B. Barry","year":"2008","unstructured":"Barry, R.B., Hughes, B.R., Cook, L.J., 2008. Involution of infantile haemangiomas after imiquimod 5% cream. Clin. Exp. Dermatol., 33(4):446\u2013449. [doi:10.1111\/j.1365-2230.2007.02676.x]","journal-title":"Clin. Exp. Dermatol."},{"issue":"4443","key":"3280_CR2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.6154315","volume":"208","author":"D. Brouty-Boy\u00e9","year":"1980","unstructured":"Brouty-Boy\u00e9, D., Zetter, B.R., 1980. Inhibition of cell motility by interferon. Science, 208(4443):516\u2013518. [doi:10.1126\/science.6154315]","journal-title":"Science"},{"issue":"4","key":"3280_CR3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaad.2006.05.017","volume":"55","author":"A.L. Bruckner","year":"2006","unstructured":"Bruckner, A.L., Frieden, I.J., 2006. Infantile Hemangiomas. J. Am. Acad. Dermatol., 55(4):671\u2013682. [doi:10.1016\/j.jaad. 2006.05.017]","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"3280_CR4","first-page":"1111","volume":"60","author":"D.G. Duda","year":"2000","unstructured":"Duda, D.G., Sunamura, M., Lozonschi, L., Kodama, T., Egawa, S., Matsumoto, G., Shimamura, H., Shibuya, K., Takeda, K., Matsuno, S., 2000. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res., 60(4):1111\u20131116.","journal-title":"Cancer Res."},{"issue":"3","key":"3280_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1007-4376(09)60051-4","volume":"23","author":"Z. Guo","year":"2009","unstructured":"Guo, Z., Li, G., Xu, Q., Gao, Y., Li, P., Zhang, X., Duan, Y., Guo, X., Zheng, B., 2009. Clinical observations on the treatment of infantile hemangiomas with topical imiquimod 5% cream. J. Nanjing Med. Univ., 23(3):177\u2013182. [doi:10.1016\/S1007-4376(09)60051-4]","journal-title":"J. Nanjing Med. Univ."},{"issue":"3","key":"3280_CR6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1525-1470.2005.22318.x","volume":"22","author":"P.G. Hazen","year":"2005","unstructured":"Hazen, P.G., Carney, J.F., Engstrom, C.W., Turgeon, K.L., Reep, M.D., Tanphaichitr, A., 2005. Proliferating haemangioma of infancy: successful treatment with topical 5% imiquimod cream. Pediatr. Dermatol., 22(3):254\u2013256. [doi:10.1111\/j.1525-1470.2005.22318.x]","journal-title":"Pediatr. Dermatol."},{"issue":"1","key":"3280_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2006.06.011","volume":"56","author":"N.T. Ho","year":"2007","unstructured":"Ho, N.T., Lansang, P., Pope, E., 2007. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J. Am. Acad. Dermatol., 56(1):63\u201368. [doi:10.1016\/j.jaad.2006.06.011]","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"3280_CR8","first-page":"708","volume":"4","author":"V.W. Li","year":"2005","unstructured":"Li, V.W., Li, W.W., Talcott, K.E., Zhai, A.W., 2005. Imiquimod as an antiangiogenic agent. J. Drugs Dermatol., 4(6):708\u2013717.","journal-title":"J. Drugs Dermatol."},{"issue":"7","key":"3280_CR9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archderm.138.7.881","volume":"138","author":"M.I. Martinez","year":"2002","unstructured":"Martinez, M.I., Sanchez-Carpintero, I., North, P.E., Mihm, M.C.Jr., 2002. Infantile haemangioma: clinical resolution with 5% imiquimod cream. Arch. Dermatol., 138(7): 881\u2013884. [doi:10.1001\/archderm.138.7.881]","journal-title":"Arch. Dermatol."},{"issue":"2","key":"3280_CR10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1525-1470.2008.00857.x","volume":"26","author":"C.C. McCuaig","year":"2009","unstructured":"McCuaig, C.C., Dubois, J., Powell, J., Belleville, C., David, M., Rousseau, E., Gendron, R., Jafarian, F., Auger, I., 2009. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr. Dermatol., 26(2):203\u2013212. [doi:10.1111\/j.1525-1470.2008.00857.x]","journal-title":"Pediatr. Dermatol."},{"issue":"4","key":"3280_CR11","first-page":"315","volume":"81","author":"M.L. Musumeci","year":"2008","unstructured":"Musumeci, M.L., Schlecht, K., Perrotta, R., Schwartz, R.A., Micali, G., 2008. Management of cutaneous hemangiomas in pediatric patients. Cutis, 81(4):315\u2013322.","journal-title":"Cutis"},{"issue":"1","key":"3280_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaad.2006.01.056","volume":"55","author":"I. Sanchez-Carpintero","year":"2006","unstructured":"Sanchez-Carpintero, I., Mart\u00ednez, M.I., Mihm, M.C.Jr., 2006. Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget\u2019s mammary disease. J. Am. Acad. Dermatol., 55(1): 75\u201379. [doi:10.1016\/j.jaad.2006.01.056]","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"3280_CR13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1523-1747.2003.12521.x","volume":"121","author":"R. Sidbury","year":"2003","unstructured":"Sidbury, R., Neuschler, N., Neuschler, E., Sun, P., Wang, X., Miller, R., Tomai, M., Puscasiu, E., Gugneja, S., Paller, A.S., 2003. Topically applied imiquimod inhibits vascular tumor growth in vivo. J. Invest. Dermatol., 121(5): 1205\u20131209. [doi:10.1046\/j.1523-1747.2003.12521.x]","journal-title":"J. Invest. Dermatol."},{"issue":"19","key":"3280_CR14","first-page":"5155","volume":"47","author":"Y.A. Sidky","year":"1987","unstructured":"Sidky, Y.A., Borden, E.C., 1987. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res., 47(19):5155\u20135161.","journal-title":"Cancer Res."},{"issue":"7","key":"3280_CR15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","volume":"27","author":"M.A. Stanley","year":"2002","unstructured":"Stanley, M.A., 2002. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin. Exp. Dermatol., 27(7):571\u2013577. [doi:10.1046\/j.1365-2230. 2002.01151.x]","journal-title":"Clin. Exp. Dermatol."},{"issue":"2","key":"3280_CR16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.mehy.2006.07.013","volume":"68","author":"Z.J. Sun","year":"2007","unstructured":"Sun, Z.J., Zhao, Y.F., Zhang, W.F., 2007. Immune response: a possible role in the pathophysiology of hemangioma. Med. Hypotheses, 68(2):353\u2013355. [doi:10.1016\/j.mehy.2006.07.013]","journal-title":"Med. Hypotheses"},{"issue":"14","key":"3280_CR17","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","volume":"358","author":"M. Seters van","year":"2008","unstructured":"van Seters, M., van Beurden, M., ten Kate, F.J., Beckmann, I., Ewing, P.C., Eijkemans, M.J., Kagie, M.J., Meijer, C.J., Aaronson, N.K., Kleinjan, A., et al., 2008. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N. Engl. J. Med., 358(14):1465\u20131473. [doi:10.1056\/NEJMoa 072685]","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"3280_CR18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1523-1747.1999.00587.x","volume":"112","author":"C. Wang","year":"1999","unstructured":"Wang, C., Quevedo, M.E., Lannutti, B.J., Gordon, K.B., Guo, D., Sun, W., Paller, A.S., 1999. In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model. J. Invest. Dermatol., 112(5):775\u2013781. [doi:10.1046\/j.1523-1747.1999. 00587.x]","journal-title":"J. Invest. Dermatol."},{"key":"3280_CR19","doi-asserted-by":"crossref","unstructured":"Wang, J.Y., Liu, L.F., Mao, X.H., 2012. Treatment of lymphangioma circumscriptum with topical imiquimod 5% cream. Dermatol. Surg., in press. [doi:10.1111\/j.1524-4725.2012.02528.x]","DOI":"10.1111\/j.1524-4725.2012.02528.x"},{"issue":"4","key":"3280_CR20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaad.2004.04.022","volume":"51","author":"O. Welsh","year":"2004","unstructured":"Welsh, O., Olazar\u00e1n, Z., G\u00f3mez, M., Salas, J., Berman, B., 2004. Treatment of infantile haemangiomas with short-term application of imiquimod 5% cream. J. Am. Acad. Dermatol., 51(4):639\u2013642. [doi:10.1016\/j.jaad. 2004.04.022]","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Zhejiang University SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1200120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1200120\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1200120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:20:52Z","timestamp":1572970852000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1200120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["3280"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1200120","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}